Plain-English translation of NCT06214156 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This clinical trial is testing a new medication called to see if it can help treat advanced melanoma (a serious type of skin cancer). Researchers want to learn whether the medication is safe, how well people tolerate it, and whether it actually helps shrink tumors or slow cancer growth.
Advanced melanoma is a life-threatening condition, and doctors need better treatment options. This medication is being studied to see if it could offer a new way to help patients with this disease.
You likely qualify if…
You likely don't qualify if…
As a participant, you would take the new medication while doctors carefully monitor your health and your cancer's response to treatment. You'll have regular visits with the research team for blood work, scans, and check-ups to make sure the treatment is working and to watch for any side effects. The study will track how your body tolerates the medication and whether your tumors shrink or stop growing.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China